Holding(s) in Company

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Bioventix Plc attached:ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights Yes An acquisition or disposal of qualifying financial instruments which may result No in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to No qualifying financial instruments An event changing the breakdown of voting rights No Other (please specify): No 3. Full name of person(s) subject to the ISIS EP LLP notification obligation:iii 4. Full name of shareholder(s) No underlying client holds over 3% (if different from 3.):iv 5. Date of the transaction and date on which the threshold is crossed or 28/06/2013 reached: v 6. Date on which issuer notified: 02/07/2013 7. Threshold(s) that is/are crossed or 5%, 6% & 7% reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type Situation previous Resulting situation after the triggering transaction of to the triggering shares transaction if possible Number Number Number Number of voting % of voting rights x using of of of shares rights the ISIN Shares Voting CODE Rights Direct Direct xi Indirect xii Direct Indirect Ord GBP Nil 0% 384,615 7.65% GB00B4QVDF07 B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. Nil C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise price Expiration Exercise/ Number of voting rights % of voting rights financial date xvii Conversion period instrument refers to xix, xx instrument xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 384,615 7.65% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi ISIS EP LLP No underlying client holds over 3% Registered name: Chase Nominees Limited Proxy Voting: 10. Name of the proxy holder: ISIS EP LLP 11. Number of voting rights proxy holder will cease N/A to hold: 12. Date on which proxy holder will cease to hold N/A voting rights: 13. Additional information: 14. Contact name: Karen Huxley 15. Contact telephone number: 020 7506 5643

Companies

Bioventix (BVXP)
UK 100